• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病通过直接和间接作用于肝细胞促进肝细胞癌的发生。

Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.

机构信息

GI-Malignancy Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

出版信息

FEBS J. 2018 Feb;285(4):752-762. doi: 10.1111/febs.14209. Epub 2017 Sep 15.

DOI:10.1111/febs.14209
PMID:28857485
Abstract

Hepatocellular carcinoma (HCC) is the sixth most frequent neoplasm and the second leading cause of cancer-related deaths worldwide. Nonalcoholic fatty liver disease (NAFLD), a common disorder in obese people, has been identified as an important risk factor for HCC. Following the increasing prevalence of obesity, it is expected that the contribution of NAFLD to HCC's incidence worldwide will grow. Recently, a number of studies have been published, which help us better understand cellular and molecular mechanisms of how NAFLD promotes hepatocarcinogensis. Inflammatory cytokines, ER stress and circadian dysregulation, which mediate hepatocyte injury and NAFLD progression, have been identified to promote malignant transformation of hepatocytes. Besides these 'intrinsic' effects, lipid dysregulation dramatically affects the liver local microenvironment. The reshaped immune environment has also been found to contribute to the NAFLD-mediated hepatocarcinogenesis. This review explores recent findings of both 'intrinsic' effects on hepatocytes and the role of the local environment in NAFLD-promoted HCC development.

摘要

肝细胞癌(HCC)是第六种最常见的肿瘤,也是全球癌症相关死亡的第二大主要原因。非酒精性脂肪性肝病(NAFLD)是肥胖人群中的一种常见疾病,已被确定为 HCC 的重要危险因素。随着肥胖症的患病率不断增加,预计 NAFLD 在全球范围内导致 HCC 发病率的贡献将会增加。最近,发表了许多研究,这些研究帮助我们更好地了解 NAFLD 促进肝癌发生的细胞和分子机制。已确定介导肝细胞损伤和 NAFLD 进展的炎症细胞因子、内质网应激和昼夜节律失调会促进肝细胞的恶性转化。除了这些“内在”作用外,脂质失调还会显著影响肝脏局部微环境。重塑的免疫环境也被发现有助于 NAFLD 介导的肝癌发生。本文综述了最近关于 NAFLD 促进 HCC 发展过程中“内在”作用对肝细胞的影响以及局部环境作用的研究进展。

相似文献

1
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes.非酒精性脂肪性肝病通过直接和间接作用于肝细胞促进肝细胞癌的发生。
FEBS J. 2018 Feb;285(4):752-762. doi: 10.1111/febs.14209. Epub 2017 Sep 15.
2
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.非酒精性脂肪性肝病导致选择性CD4(+) T淋巴细胞丢失并促进肝癌发生。
Nature. 2016 Mar 10;531(7593):253-7. doi: 10.1038/nature16969. Epub 2016 Mar 2.
3
Deranged hepatocyte intracellular Ca homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.肝细胞内 Ca 稳态紊乱与非酒精性脂肪性肝病向肝细胞癌的进展。
Cell Calcium. 2019 Sep;82:102057. doi: 10.1016/j.ceca.2019.102057. Epub 2019 Jul 26.
4
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
5
Apoptosis and non-alcoholic fatty liver diseases.细胞凋亡与非酒精性脂肪性肝病。
World J Gastroenterol. 2018 Jul 7;24(25):2661-2672. doi: 10.3748/wjg.v24.i25.2661.
6
Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.分析斑马鱼非酒精性脂肪性肝病相关肝细胞癌早期进展过程中的肝微环境。
J Vis Exp. 2021 Apr 1(170). doi: 10.3791/62457.
7
NAFLD-related HCC.非酒精性脂肪性肝病相关肝细胞癌。
Adv Cancer Res. 2021;149:143-169. doi: 10.1016/bs.acr.2020.11.001. Epub 2021 Jan 21.
8
Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.过氧化物酶体 β-氧化调节全身代谢、炎症活力和非酒精性脂肪性肝病的发病机制。
JCI Insight. 2018 Mar 22;3(6):93626. doi: 10.1172/jci.insight.93626.
9
Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.肝细胞癌与非酒精性脂肪性肝炎:现状
World J Gastroenterol. 2016 Feb 28;22(8):2494-502. doi: 10.3748/wjg.v22.i8.2494.
10
Autophagy, NAFLD and NAFLD-Related HCC.自噬、非酒精性脂肪性肝病和非酒精性脂肪性肝病相关的肝细胞癌。
Adv Exp Med Biol. 2018;1061:127-138. doi: 10.1007/978-981-10-8684-7_10.

引用本文的文献

1
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis.单核细胞生物能量学:代谢功能障碍相关脂肪性肝炎的免疫代谢观点。
Cell Rep Med. 2024 May 21;5(5):101564. doi: 10.1016/j.xcrm.2024.101564. Epub 2024 May 10.
2
Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions.由肝细胞线粒体功能障碍驱动的 NASH 中的炎症信号转导。
J Transl Med. 2023 Oct 26;21(1):757. doi: 10.1186/s12967-023-04627-0.
3
suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6 natural killer T cells.
通过 CXCR6 自然杀伤 T 细胞抑制非酒精性脂肪性肝炎相关肿瘤发生。
Front Immunol. 2022 Dec 1;13:1047570. doi: 10.3389/fimmu.2022.1047570. eCollection 2022.
4
Prostaglandin 2α Promotes Autophagy and Mitochondrial Energy Production in Fish Hepatocytes.前列腺素 2α 促进鱼类肝细胞自噬和线粒体能量生成。
Cells. 2022 Jun 9;11(12):1870. doi: 10.3390/cells11121870.
5
Distinct hepatic immunological patterns are associated with the progression or inhibition of hepatocellular carcinoma.不同的肝脏免疫模式与肝细胞癌的进展或抑制有关。
Cell Rep. 2022 Mar 1;38(9):110454. doi: 10.1016/j.celrep.2022.110454.
6
The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease.体育活动在非酒精性和代谢功能障碍相关脂肪性肝病中的作用
Biomedicines. 2021 Dec 7;9(12):1853. doi: 10.3390/biomedicines9121853.
7
A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies.AMPK 在非酒精性脂肪性肝病从头合成脂肪中的作用的叙事性综述:来自人体研究的证据。
Cells. 2021 Jul 19;10(7):1822. doi: 10.3390/cells10071822.
8
The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者中与肝细胞癌相关的基因特征
J Oncol. 2021 Apr 2;2021:6630535. doi: 10.1155/2021/6630535. eCollection 2021.
9
Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer.将非酒精性脂肪性肝炎与癌症联系起来的分子机制
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):6-10. doi: 10.1002/cld.1006. eCollection 2021 Jan.
10
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A Review.免疫检查点阻断在肝细胞癌中的现状:综述。
JAMA Oncol. 2021 Jan 1;7(1):113-123. doi: 10.1001/jamaoncol.2020.3381.